Asker Healthcare Group AB (publ) (STO:ASKER)

Market Cap	26.68B -19.2%
Revenue (ttm)	18.01B +13.4%
Net Income	715.00M +70.1%
EPS	1.87 +46.1%
Shares Out	383.04M
PE Ratio	36.92
Forward PE	21.74
Dividend	0.39 (0.56%)
Ex-Dividend Date	May 8, 2026

Volume	198,345
Open	68.40
Previous Close	68.90
Day's Range	68.40 - 70.10
52-Week Range	56.20 - 95.56
Beta	n/a
Analysts	Buy
Price Target	89.90 (+29.07%)
Earnings Date	Nov 4, 2026

About Asker Healthcare Group AB

Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics; defibrillators and wound care products. In addition, ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2006
• Employees: 4,885
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ASKER

Financial Performance

In 2025, Asker Healthcare Group AB's revenue was 16.79 billion, an increase of 11.73% compared to the previous year's 15.03 billion. Earnings were 492.00 million, an increase of 36.67%.

Analyst Summary

According to 5 analysts, the average rating for ASKER stock is "Buy." The 12-month stock price target is kr 89.90, which is an increase of 29.07% from the latest price.

Price Target

kr 89.90

(29.07% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 13, 2026

Data Sources Report a data error